Adenosine triphosphate-binding cassette transporters: key players in maintaining fetal health during pregnancy - Report - MDSpire

Adenosine triphosphate-binding cassette transporters: key players in maintaining fetal health during pregnancy

  • By

  • Xian-Hong Wang

  • Ghazala Saeed

  • Ali Afzal

  • Umair Ali Khan Saddozai

  • Gui-Min Shao

  • Amna Rehman

  • Syeda Eisha Hamid

  • Si-Ying Pan

  • Xin-Ying Ji

  • Muhammad Babar Khawar

  • July 16, 2026

Share

Clinical Report: ATP-Binding Cassette Transporters and Fetal Well-Being

Overview

ATP-binding cassette (ABC) transporters are involved in fetal metabolic homeostasis and chemical exposure during gestation. Their dysfunction is linked to several obstetric complications.

Background

ABC transporters are essential for maintaining the balance of nutrients and protecting the fetus from harmful substances during pregnancy. Dysfunction can lead to significant maternal and fetal health issues.

Data Highlights

No numerical data or trial data provided in the article.

Key Findings

  • ABC transporters are involved in the transport of nutrients and the efflux of xenobiotics at the maternal-fetal interface.
  • Key transporters include P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2).
  • Dysfunction of ABC transporters is implicated in preeclampsia, gestational diabetes mellitus, and other obstetric complications.
  • Mechanisms affecting transporter function include NRF2-dependent antioxidant signaling and HIF-1α-dependent suppression of BCRP.
  • Clinical pharmacogenomics opportunities include ABCG2 Q141K genotyping for glyburide prescribing in gestational diabetes.

Clinical Implications

Clinicians should be aware of the role of ABC transporters in fetal health and the potential impact of their dysfunction on pregnancy outcomes.

Conclusion

ABC transporters are critical for fetal well-being throughout gestation, and their dysfunction can lead to serious obstetric complications.

Related Resources & Content

  1. Frontiers in Endocrinology, 2026 -- Placental expression and activity of system A and system L amino acid transporters in pregnancies complicated by diabetes mellitus and fetal growth disorders: a systematic review
  2. Pediatric Cardiology, 2025 -- Clinical Case of TRAP Sequence: Can a Single Umbilical Artery Serve as an Ultrasound Indicator for Fetal Heart Failure Risk?
  3. BMC Pregnancy and Childbirth, 2026 -- Intrapartum cardiotocographic patterns and perinatal outcomes in extremely preterm births: an exploratory retrospective cohort study
  4. Frontiers in Immunology, 2026 -- FABP4 as an Immunometabolic Hub in Preeclampsia: From Maternal-Fetal Interface to Systemic Inflammation
  5. Physiological and anatomical determinants of placental drug transfer - Lewis - The Journal of Physiology - Wiley Online Library, 2026
  6. Absolute membrane protein abundance of P-glycoprotein, breast cancer resistance protein, and multidrug resistance proteins in term human placenta tissue and commonly used cell systems: Application in physiologically based pharmacokinetic modeling of placental drug disposition - ScienceDirect, 2026
  7. The Latest on Intrahepatic Cholestasis of Pregnancy – Update 2026 - PMC
  8. SOGC Diagnosis and Management of Intrahepatic Cholestasis of Pregnancy Guideline Summary - Guideline Central, 2026
  9. Mechanistic background at the maternal–fetal interface
  10. Absolute membrane protein abundance of P-glycoprotein, breast cancer resistance protein, and multidrug resistance proteins in term human placenta tissue
  11. The Latest on Intrahepatic Cholestasis of Pregnancy – Update 2026 - PMC
  12. SOGC Diagnosis and Management of Intrahepatic Cholestasis of Pregnancy Guideline Summary - Guideline Central
  13. Introduction: Treatment of HIV During Pregnancy and Prevention of Perinatal Transmission | NIH
  14. FDA Issues Guidance to Improve Collection of Pregnancy Safety Data for Drugs and Biologics | FDA

Original Source(s)

Related Content